Park B J, Heerdt P M
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Minerva Chir. 2009 Dec;64(6):573-88.
Non-small cell lung cancer (NSCLC) remains one of the leading causes of cancer-related mortality worldwide. Despite recent advances in molecular characterization, targeted and adjuvant therapies of NSCLC, surgical resection remains the mainstay of curative treatment. Minimally invasive video-assisted thoracic surgery (VATS) techniques, in particular VATS lobectomy, are being increasingly utilized over traditional thoracotomy approaches in the treatment of localized NSCLC for the reported benefits with respect to postoperative recovery and the conviction of oncologic equivalence. This article will review the major VATS procedures, including their development, outcomes, and purported advantages over thoracotomy, as well as highlight new advances, such as robotic-assisted procedures.
非小细胞肺癌（NSCLC）仍然是全球癌症相关死亡的主要原因之一。尽管近年来在NSCLC的分子特征分析、靶向治疗和辅助治疗方面取得了进展，但手术切除仍然是根治性治疗的主要手段。与传统开胸手术相比，微创电视辅助胸腔镜手术（VATS）技术，特别是VATS肺叶切除术，因其在术后恢复方面的优势以及肿瘤学等效性的确证，在局限性NSCLC的治疗中越来越多地被采用。本文将回顾主要的VATS手术，包括其发展、结果以及相对于开胸手术的据称优势，并重点介绍新进展，如机器人辅助手术。
